Business Daily from THE HINDU group of publications
Thursday, Jul 17, 2008
ePaper | Mobile/PDA Version | Audio


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Credit Rating
Fitch rates Aurobindo's loan `A+'

Hyderabad, July 16

The bank loan facilities of Aurobindo Pharma Ltd have been assigned a national issuer rating of `A+' with a stable outlook by Fitch. The national ratings denote a strong credit risk relative to other issuers or issues in the same country. "The ratings reflect APL's strong revenue growth, its strong foothold in the active pharmaceutical ingredient space, as well as its demonstrated ability in growing its formulation business," the Hyderabad-based company said in a release. - Our Bureau

More Stories on : Credit Rating | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
BHEL bags Rs 160-cr UAE order


TRF wins 2 orders
BGR Energy wins Rs 5,023-cr contract from Rajasthan Vidyut
Fitch rates Aurobindo's loan `A+'
Deal with Daiichi Sankyo well on track, says Ranbaxy chief
Toshiba plans to set up Rs 1,000-cr boiler plant near Chennai
QVC Realty to launch first project in Bangalore soon
Parsvnath picks up 38% stake in Nano City project
Nagarjuna Construction to invest up to Rs 500 cr in airports, ports
Pressmart, US magazine tie-up
Controls & Switchgear raises Rs 100 cr
Realty developer Bearys starts Montessori schools
ONGC plans to relinquish Barmer-Sanchor CBM block
Volkswagen sets 2010 launch date for small car Polo
India on Novartis’ radar for prospecting bio-resources


Brandline



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line